FYERS
Home
/
Stocks
/
Profit Loss
/
RPG Life Sciences Profit & Loss

RPG Life Sciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Jun 2025Mar 2025Dec 2024
₹196 Cr₹177 Cr₹180 Cr₹169 Cr₹143 Cr₹173 Cr
₹5 Cr₹12 Cr₹3 Cr₹5 Cr₹5 Cr₹3 Cr
₹200 Cr₹189 Cr₹183 Cr₹174 Cr₹148 Cr₹176 Cr
₹158 Cr₹150 Cr₹146 Cr₹139 Cr₹123 Cr₹129 Cr
₹48 Cr₹45 Cr₹43 Cr₹41 Cr₹31 Cr₹52 Cr
₹63 L₹39 L₹25 L₹13 L₹18 L₹12 L
₹41 Cr₹40 Cr₹29 Cr₹35 Cr₹135 Cr₹47 Cr
₹31 Cr₹30 Cr₹22 Cr₹26 Cr₹117 Cr₹35 Cr

Share Price Live Stats

Open (₹)2,814.80
Volume (₹)5,256.00
High (₹)2,837.90
Upper Circuit3,367.90
Low (₹)2,781.50
Lower Circuit2,245.30
Prev Close2,806.60
52W High (₹)3,127.80
Price2,825.00
52W Low (₹)1,733.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)4647.30 Cr
Div. Yield (%)0.85
PE Ratio40.35
Debt to Equity0.03
Price to Book5.05
Book Value366.05
EPS (TTM)69.64
Face Value8.00
ROE (%)20.28

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
RPGLIFENSE
LTP
1W Low
1W High
Market cap (₹)
1746.4-13.6 (-0.77%)
1725.50
1776.60
4,24,466Cr
9023-317 (-3.39%)
8937.50
9431.50
2,46,222Cr
4580-76.9 (-1.65%)
4551.80
4682
1,76,301Cr
1124.7+7.2 (0.64%)
1107.30
1150.90
1,12,818Cr
2036.9+0.3 (0.01%)
2007.80
2069.20
1,10,823Cr
1314.6+13.6 (1.05%)
1300.20
1333.30
1,07,447Cr
1216+19 (1.59%)
1196.90
1250.70
1,03,471Cr
2335-33.5 (-1.41%)
2317.50
2426.80
97,850Cr
1662.9-30.1 (-1.78%)
1654.10
1715
96,836Cr
1953.2-3.3 (-0.17%)
1925.70
1964.90
89,629Cr
2825+105.8 (3.89%)
2705.10
2894.90
4,647Cr

Key Highlights of RPG Life Sciences Ltd’s P&L

In 2026-03-31, RPG Life Sciences Ltd reported total revenue of ₹733.1Cr, compared with ₹667.76Cr in 2025-03-31, reflecting RPG Life Sciences Ltd turnover.

Depreciation was ₹21.48Cr and finance costs were ₹1.77Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹154.2Cr in 2026-03-31 as compared to ₹232.88Cr in 2025-03-31.

Net Profit (PAT) was ₹115.17Cr in 2026-03-31 compared with ₹183.24Cr in 2025-03-31.

Earnings per share (EPS) were ₹69.64 in 2026-03-31, compared with ₹110.80 in 2025-03-31.